BOUT vs. IBID
BOUT (Innovator IBD Breakout Opportunities ETF) and IBID (iShares iBonds Oct 2027 Term TIPS ETF) are both exchange-traded funds - BOUT is a Mid Cap Growth Equities fund tracking the IBD Breakout Stocks Total Return Index, while IBID is a Inflation-Protected Bonds fund tracking the ICE 2027 Maturity US Inflation-Linked Treasury Index. Both are passively managed. Over the past year, BOUT returned 38.59% vs 4.04% for IBID. At a correlation of -0.01, they often move in opposite directions. BOUT charges 0.80%/yr vs 0.10%/yr for IBID.
Performance
BOUT vs. IBID - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BOUT achieves a 34.44% return, which is significantly higher than IBID's 1.99% return.
BOUT
- 1D
- 1.34%
- 1M
- 5.57%
- YTD
- 34.44%
- 6M
- 31.27%
- 1Y
- 38.59%
- 3Y*
- 17.65%
- 5Y*
- 8.92%
- 10Y*
- —
IBID
- 1D
- 0.00%
- 1M
- -0.19%
- YTD
- 1.99%
- 6M
- 2.08%
- 1Y
- 4.04%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
BOUT vs. IBID - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
BOUT Innovator IBD Breakout Opportunities ETF | 34.44% | -6.77% | 18.82% | 6.00% |
IBID iShares iBonds Oct 2027 Term TIPS ETF | 1.99% | 5.66% | 4.71% | 2.61% |
Correlation
The correlation between BOUT and IBID is -0.15, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.15 |
Correlation (All Time) Calculated using the full available price history since Sep 15, 2023 | -0.01 |
The correlation between BOUT and IBID shifts across timeframes, from -0.15 (1 year) to -0.01 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BOUT vs. IBID — Risk / Return Rank
BOUT
IBID
BOUT vs. IBID - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Innovator IBD Breakout Opportunities ETF (BOUT) and iShares iBonds Oct 2027 Term TIPS ETF (IBID). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BOUT | IBID | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.51 | ||
| Sortino ratioReturn per unit of downside risk | -3.18 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.75 | -0.44 |
| Calmar ratioReturn relative to maximum drawdown | 3.30 | 8.22 | -4.92 |
| Martin ratioReturn relative to average drawdown | 9.76 | 30.99 | -21.24 |
Loading charts...
Drawdowns
BOUT vs. IBID - Drawdown Comparison
The maximum BOUT drawdown since its inception was -36.98%, which is greater than IBID's maximum drawdown of -1.28%. Use the drawdown chart below to compare losses from any high point for BOUT and IBID.
Loading charts...
Drawdown Indicators
| BOUT | IBID | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -36.98% | -1.28% | -35.70% |
Max Drawdown (1Y)Largest decline over 1 year | -11.76% | -0.49% | -11.27% |
Max Drawdown (3Y)Largest decline over 3 years | -25.31% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -28.28% | — | — |
Current DrawdownCurrent decline from peak | 0.00% | -0.49% | +0.49% |
Average DrawdownAverage peak-to-trough decline | -12.30% | -0.22% | -12.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.97% | 0.13% | +3.84% |
Volatility
BOUT vs. IBID - Volatility Comparison
Innovator IBD Breakout Opportunities ETF (BOUT) has a higher volatility of 7.96% compared to iShares iBonds Oct 2027 Term TIPS ETF (IBID) at 0.35%. This indicates that BOUT's price experiences larger fluctuations and is considered to be riskier than IBID based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BOUT | IBID | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.96% | 0.35% | +7.61% |
Volatility (6M)Calculated over the trailing 6-month period | 17.13% | 0.86% | +16.27% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.87% | 1.23% | +20.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.69% | 2.24% | +17.45% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.00% | 2.24% | +20.76% |
BOUT vs. IBID - Expense Ratio Comparison
BOUT has a 0.80% expense ratio, which is higher than IBID's 0.10% expense ratio.
Dividends
BOUT vs. IBID - Dividend Comparison
BOUT's dividend yield for the trailing twelve months is around 0.26%, less than IBID's 3.68% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
BOUT Innovator IBD Breakout Opportunities ETF | 0.26% | 0.34% | 0.60% | 1.32% | 1.35% | 0.00% | 0.00% | 0.00% | 0.22% |
IBID iShares iBonds Oct 2027 Term TIPS ETF | 3.68% | 4.43% | 4.24% | 0.81% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BOUT and IBID have a correlation of -0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BOUT has higher volatility (7.96%) compared to IBID (0.35%). In terms of maximum drawdown, BOUT dropped -36.98% vs IBID's -1.28%.
On 1-year performance, BOUT leads with 38.59% vs 4.04% for IBID. On fees, IBID is cheaper at 0.10% per year. On volatility, IBID has been the lower-risk option at 0.35%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, BOUT has performed better with a 38.59% return vs 4.04%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IBID is cheaper with a 0.10% expense ratio, compared with 0.80% for BOUT.
IBID has the higher dividend yield at 3.68%, compared with 0.26% for BOUT.
BOUT is categorized as Mid Cap Growth Equities, while IBID is Inflation-Protected Bonds. BOUT tracks IBD Breakout Stocks Total Return Index, while IBID tracks ICE 2027 Maturity US Inflation-Linked Treasury Index. They also come from different issuers: Innovator and iShares. Their fees differ too: 0.80% for BOUT and 0.10% for IBID.
IBID currently has the higher Sharpe Ratio (3.29 vs 1.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BOUT and IBID
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer